BridgeMD
New treatment option for Narcolepsy Type 1
Official title Deciphering the Interactions Between Food Intake, Sleepiness, and Nighttime Sleep Quality in Patients With Type 1 Narcolepsy and Idiopathic Hypersomnia
ClinicalTrials.gov ID: NCT06484348
What this study is testing
- What it's testing
- Links between sleep and food intake are manyfold. In healthy individuals, sleep deprivation promotes obesity by stimulating food intake of high glycemic index (GI) foods.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65. Healthy volunteers may be eligible.
You may be able to join if
- Patients with NT1 or IH (ICSD-3-TR) or Healthy Controls without sleep disorder
- Familiar use of a smartphone
You likely can't join if
- Untreated moderate or severe sleep apnea syndrome;
- Cognitive disorders incompatible with the protocol;
- Unstable treatment or treatment with sodium oxybate;
- Unstable medical or psychiatric pathology;
- Shift work;
- Pregnancy or breastfeeding;
See the full eligibility criteria
- Patients with NT1 or IH (ICSD-3-TR) or Healthy Controls without sleep disorder
- Familiar use of a smartphone
- Untreated moderate or severe sleep apnea syndrome;
- Cognitive disorders incompatible with the protocol;
- Unstable treatment or treatment with sodium oxybate;
- Unstable medical or psychiatric pathology;
- Shift work;
- Pregnancy or breastfeeding;
- Diabetes
The study team makes the final eligibility decision.
Where it's taking place
- Clermont-Ferrand, France
- Lyon, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Clermont-Ferrand, France; Lyon, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.